Funding Announcements

"Together with genetics, the concept of personalised medicine requires a dynamic approach. Genomics provides the blueprint of where we begin, but health is not static—it evolves with time, environment, and lifestyle. To truly transform care, we must complement genomic insights with modifiable biomarkers: biological signals that capture real-time responses to interventions and track improvement longitudinally. This synergy between genomics and adaptive biomarkers is the cornerstone for turning personalised medicine from a descriptive concept into actionable, measurable, and preventative healthcare."

"We see strong potential in Digilytics and its plug-and-play AI technology, which is solving critical pain points for lenders and is readily transferable to adjacent verticals. Designed to integrate seamlessly with existing loan origination and case management systems, the technology offers a value-driven solution that’s already demonstrating scalability through rapid ARR growth and low customer churn. Arindom brings deep financial services expertise and a clear understanding of how to serve large, highly regulated organisations, positioning Digilytics as a standout operator in a market ripe for transformation."

"Ranking Copilot is a prime example of what we are looking for — a world-class product from a Ukrainian team that uses AI to solve a pressing global problem. The partnership with Chambers gives them an advantage in distribution and trust that almost no early-stage legal tech startup has access to"

"Invention is how we solve humanity’s biggest challenges, yet the systems that protect those ideas are decades out of date. AI will redefine how global organisations innovate over the next five years, turning IP from a cost centre into a growth driver. The companies that adopt Ankar now will shape the future of innovation."

"This funding accelerates our transition into a new era where AI agents leave the screen and enter the factory floor."